News & Events - Center for the Evaluation of Value and Risk in Health

Publications

Health Policy Open

Variation in Medicaid and commercial coverage of cell and gene therapies

Health Affairs Forefront

The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA

The American Journal of Managed Care

Varied Use of Step Therapy Among Medicare Advantage Plans

The Milbank Quarterly

Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval

Cost Effectiveness and Resource Allocation

Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol

The New England Journal of Medicine

Turning CMS into a health technology assessment organization

JAMA Network Open

Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act

Journal of Market Access & Health Policy

Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseases

Health Affairs Scholar

Commercial Coverage of Specialty Drugs 2017-2021

View All Publications